GB/T 16886.9-2022
Biological Evaluation of Medical Devices Part 9: Qualitative and Quantitative Framework for Potential Degradation Products (English Version)

Standard No.
GB/T 16886.9-2022
Language
Chinese, Available in English version
Release Date
2022
Published By
General Administration of Quality Supervision, Inspection and Quarantine of the People‘s Republic of China
Latest
GB/T 16886.9-2022
Replace
GB/T 16886.9-2017
Scope
This document specifies the basic principles for the systematic evaluation of potential and observed degradation of medical devices through the design and conduct of in vitro degradation studies. The information obtained from these studies can be used for the biological evaluation described in the GB/T(Z)16886 series of standards. This document applies to materials that are expected to degrade in vivo as well as materials that do not degrade. This document does not apply to: a) Evaluation of degradation produced by purely mechanical processes; see specific product standards (if any) for the methodology for producing such degradation products; Note: Purely mechanical degradation mainly produces particulate matter. Although not included in the scope of this document, such degradation products can cause biological reactions, and biological evaluation can be carried out according to the methods described in other parts of GB/T(Z)16886. b) leachable components that are not degradation products; c) medical devices or components that do not directly or indirectly contact patients.

GB/T 16886.9-2022 Referenced Document

  • ISO 10993-1 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
  • ISO 10993-2 Biological evaluation of medical devices — Part 2: Animal welfare requirements

GB/T 16886.9-2022 history

  • 2022 GB/T 16886.9-2022 Biological Evaluation of Medical Devices Part 9: Qualitative and Quantitative Framework for Potential Degradation Products
  • 2017 GB/T 16886.9-2017 Biological evaluation of medical devices—Part 9: Framework for identification and quantification of potential degradation products
  • 2001 GB/T 16886.9-2001 Biological evaluation of medical devices-Part 9:Framework for identification and quantification of potential degradation product
Biological Evaluation of Medical Devices Part 9: Qualitative and Quantitative Framework for Potential Degradation Products

GB/T 16886.9-2022 -All Parts

GB/T 16886.1-2022 Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process GB/T 16886.10-2017 Biological evaluation of medical devices—Part 10: Tests for irritation and skin sensitization GB/T 16886.11-2021 Biological evaluation of medical devices—Part 11: Tests for systemic toxicity GB/T 16886.12-2023 Biological Evaluation of Medical Devices Part 12: Sample Preparation and Reference Materials GB/T 16886.13-2017 Biological evaluation of medical devices—Part 13: Identification and quantification of degradation products from polymeric medical devices GB/T 16886.14-2003 Biological evaluation of medical devices--Part 14: Identification and quantification of degradation products from ceramics GB/T 16886.15-2022 Biological evaluation of medical devices—Part 15: Identification and quantification of degradation products from metals and alloys GB/T 16886.16-2021 Biological evaluation of medical devices—Part 16: Toxicokinetic study design for degradation products and leachables GB/T 16886.17-2005 Biological evaluation of medical devices.Part 17:Establishment of allowable limits for leachable substances GB/T 16886.18-2022 Biological evaluation of medical devices—Part 18: Chemical characterization of medical device materials within a risk management process GB/T 16886.19-2022 Biological evaluation of medical devices—Part 19: Physico-chemical, morphological and topographical characterization of materials GB/T 16886.2-2011 Biological evaluation of medical devices.Part 2: Animal welfare requirements GB/T 16886.20-2015 Biological evaluation of medical devices.Part 20:Principles and methods for immunotoxicology testing of medical devices GB/T 16886.23-2023 Biological Evaluation of Medical Devices Part 23: Stimulation Test GB/T 16886.3-2019 Biological evaluation of medical devices—Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity GB/T 16886.4-2022 Biological evaluation of medical devices—Part 4: Selection of tests for interactions with blood GB/T 16886.5-2017 Biological Evaluation of Medical Devices Part 5: In Vitro Cytotoxicity Tests GB/T 16886.6-2022 Biological evaluation of medical devices—Part 6:Tests for local effects after implantation GB/T 16886.7-2015 Biological evaluation of medical devices—Part 7: Ethylene oxide sterilization residuals GB/T 16886.9-2022 Biological Evaluation of Medical Devices Part 9: Qualitative and Quantitative Framework for Potential Degradation Products



Copyright ©2024 All Rights Reserved